Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration

Por Giovannoni, Sara, Trenta, Patrizia
Publicado em 2014

Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature

Por Iacovelli, Roberto, Modica, Daniela, Palazzo, Antonella, Trenta, Patrizia, Piesco, Gabriele, Cortesi, Enrico
Publicado no Can Urol Assoc J (2015)

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

Por Iacovelli, Roberto, Palazzo, Antonella, Procopio, Giuseppe, Santoni, Matteo, Trenta, Patrizia, De Benedetto, Angelina, Mezi, Silvia, Cortesi, Enrico
Publicado em 2014

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

Por Vici, Patrizia, Pizzuti, Laura, Natoli, Clara, Moscetti, Luca, Mentuccia, Lucia, Vaccaro, Angela, Sergi, Domenico, Di Lauro, Luigi, Trenta, Patrizia, Seminara, Patrizia, Santini, Daniele, Iezzi, Laura, Tinari, Nicola, Bertolini, Ilaria, Sini, Valentina, Mottolese, Marcella, Giannarelli, Diana, Giotta, Francesco, Maugeri-Saccà, Marcello, Barba, Maddalena, Marchetti, Paolo, Michelotti, Andrea, Sperduti, Isabella, Gamucci, Teresa
Publicado em 2014